More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

In the never-ending fight against obesity, the people of Philadelphia have been looking for a solution that is not only ...

Tia Timmer was always “on the heavier side,” but her weight never held her back – until she had to keep up with two grandchildren.

In the face of economic and social precarity, many members of Gen Z have stepped away from abundance and instead opted for ...

Altimmune stock: 48-week pemvidutide MASH data, FDA Breakthrough Therapy boost, but rising competition and cash needs. Click ...

TAMPA, Fla. — New year, new me. That’s a phrase often heard at the start of the new year, especially when it comes to being healthy and weight loss. In recent years, there have been breakthroughs with ...

When he outpointed Lopes the first time, Volkanovski became the oldest fighter to win the featherweight title, so (duh) he ...

In December, Novo Nordisk announced that the Food and Drug Administration had approved its once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the United States. It remains the only ...

Despite overwhelming roster turnover, No. 12 TCU is still elite. Their excellence begins on the defensive end.

What would you do if your best friend's father killed your abusive father? P. R. Monencillo Patindol's feature examines grief ...

Novo Nordisk has global metabolic leadership, an oral GLP-1 program, and a stock price below $50 after a retail-driven ...

How to tell if North Carolina pharma pledges are tariff dodges, legit or both. Pus, the EPA wants to adopt out RTP testing ...